OHSU in the news

A patient's guide to cataract surgery

U.S. News & World Report February 23, 2020
A feature regarding cataract surgery includes expertise from Mitchell Brinks, M.D., M.P.H., about procedure benefits, risks and outcomes.

Changing the face of health care

WSU Insider February 21, 2020
OHSU’s involvement in a joint project to increase Native American representation in medical and health science schools is featured.

Antigen-based metric could better predict which patients benefit from immunotherapy, study says

STAT February 21, 2020
In a story about a new metric that could help predict whether patients will respond to immunotherapies, Vinay Prasad, M.D., M.P.H., says: “Even in cancers where immunotherapy has no FDA approvals, patients ask for it, in part because they’ve heard about it on the news or TV. But, we have also seen many patients for whom immunotherapy has caused devastating side effects.”

Spravato debate still rages

Medpage Today February 20, 2020
In a story about ongoing debate over the effectiveness and safety of the new FDA-approved antidepressant nasal spray esketamine, Erick Turner, M.D., says: “In the case of esketamine, you have this unmet need, this drum that gets pounded over and over again: People are dying and we don't have anything for them. But that actually makes the data all the more disappointing”.

Komen, community battling African-American breast cancer

KOIN-TV February 20, 2020
Rochelle Williams-Belizaire speaks about Susan G. Komen’s African-American Advisory Council, aimed to glean input on breast cancer initiatives from the African-American community. She says: “Despite relative screening efforts and the incidents for the disease, for some reason African-Americans are more susceptible.”
See more stories